Showing 1 to 12 of 75 results
Moscow reports 2000 robotic surgeries in first 7 months of 2025
Moscow Mayor Sergey Sobyanin reported that 2000 robotic surgeries were performed in the first seven months of 2025, matching the total number for all of 2024, marking robotic surgery's rise as a new standard in cancer treatment.
Moscow reports 2000 robotic surgeries in first 7 months of 2025
Moscow Mayor Sergey Sobyanin reported that 2000 robotic surgeries were performed in the first seven months of 2025, matching the total number for all of 2024, marking robotic surgery's rise as a new standard in cancer treatment.
Progress
48% Bias Score
Universal Cancer Vaccine Shows Promise in Mice Studies
A new mRNA-based cancer vaccine, tested on mice with various cancers, demonstrates potential as a universal treatment, shrinking or eliminating tumors when combined with immunotherapy, improving survival rates significantly; however, human trials are still needed.
Universal Cancer Vaccine Shows Promise in Mice Studies
A new mRNA-based cancer vaccine, tested on mice with various cancers, demonstrates potential as a universal treatment, shrinking or eliminating tumors when combined with immunotherapy, improving survival rates significantly; however, human trials are still needed.
Progress
52% Bias Score
Exercise Significantly Reduces Colon Cancer Recurrence and Mortality
A new study shows that structured exercise programs for colon cancer patients after treatment resulted in a 28% lower risk of cancer recurrence and a 37% lower risk of death compared to the control group, suggesting a significant improvement in survival outcomes.
Exercise Significantly Reduces Colon Cancer Recurrence and Mortality
A new study shows that structured exercise programs for colon cancer patients after treatment resulted in a 28% lower risk of cancer recurrence and a 37% lower risk of death compared to the control group, suggesting a significant improvement in survival outcomes.
Progress
44% Bias Score
Lenovo's HPC System Accelerates Cancer and Cardiology Research in Milan
Lenovo provided the IEO Monzino Group in Milan with a 475 TFlop HPC system using Lenovo ThinkSystem servers and NVIDIA H200 GPUs to accelerate cancer and cardiology research, enabling faster analysis of protein interactions and clinical data for improved diagnostics, prognostics, and personalized tr...
Lenovo's HPC System Accelerates Cancer and Cardiology Research in Milan
Lenovo provided the IEO Monzino Group in Milan with a 475 TFlop HPC system using Lenovo ThinkSystem servers and NVIDIA H200 GPUs to accelerate cancer and cardiology research, enabling faster analysis of protein interactions and clinical data for improved diagnostics, prognostics, and personalized tr...
Progress
32% Bias Score
Sharp Rise in Appendix Cancer Among Young Americans Raises Concerns
A study in Annals of Internal Medicine reveals a dramatic increase in appendix cancer among younger US-born individuals, with those born in 1980 having triple and those born in 1985 having almost quadruple the risk compared to those born in 1945, suggesting a potential link to lifestyle changes or e...
Sharp Rise in Appendix Cancer Among Young Americans Raises Concerns
A study in Annals of Internal Medicine reveals a dramatic increase in appendix cancer among younger US-born individuals, with those born in 1980 having triple and those born in 1985 having almost quadruple the risk compared to those born in 1945, suggesting a potential link to lifestyle changes or e...
Progress
20% Bias Score
Exercise Significantly Improves Colon Cancer Survival Rates
A three-year exercise program for 889 colon cancer survivors resulted in a 28% lower cancer recurrence and 37% lower mortality rate compared to a control group receiving educational materials, highlighting exercise as a potential standard treatment.
Exercise Significantly Improves Colon Cancer Survival Rates
A three-year exercise program for 889 colon cancer survivors resulted in a 28% lower cancer recurrence and 37% lower mortality rate compared to a control group receiving educational materials, highlighting exercise as a potential standard treatment.
Progress
52% Bias Score
Global Cancer Research Funding: A Disparity in Investment
A study in The Lancet Oncology reveals that while \$51.4 billion was invested globally in cancer research between 2016 and 2023, funding disparities exist between high-income and low-income countries, with the US contributing the most and low-income countries receiving only \$48.4 million.
Global Cancer Research Funding: A Disparity in Investment
A study in The Lancet Oncology reveals that while \$51.4 billion was invested globally in cancer research between 2016 and 2023, funding disparities exist between high-income and low-income countries, with the US contributing the most and low-income countries receiving only \$48.4 million.
Progress
16% Bias Score
Cancer Research: Challenges and Advancements in Immunotherapy
A German podcast episode, "Aha! Ten Minutes of Everyday Knowledge," features Professor Stefan Fröhling discussing cancer research, highlighting challenges in rare cancers, the potential of immunotherapies (currently effective in 20% of patients), and the need for more personalized treatment strategi...
Cancer Research: Challenges and Advancements in Immunotherapy
A German podcast episode, "Aha! Ten Minutes of Everyday Knowledge," features Professor Stefan Fröhling discussing cancer research, highlighting challenges in rare cancers, the potential of immunotherapies (currently effective in 20% of patients), and the need for more personalized treatment strategi...
Progress
36% Bias Score
Genomic Instability Test Predicts Chemotherapy Failure in Cancer Patients
Researchers in Spain and the UK have developed a new genomic instability analysis that predicts which patients will not respond to three major chemotherapy types, impacting treatment decisions and potentially reducing side effects for up to 50% of patients.
Genomic Instability Test Predicts Chemotherapy Failure in Cancer Patients
Researchers in Spain and the UK have developed a new genomic instability analysis that predicts which patients will not respond to three major chemotherapy types, impacting treatment decisions and potentially reducing side effects for up to 50% of patients.
Progress
36% Bias Score
Rome Oncology Conference: Integrating Care and Precision Medicine
A two-day oncology conference in Rome (June 13-14) will focus on integrating hospital and territorial care and precision medicine to improve cancer treatment and patient outcomes in Italy, aligning with the National Recovery and Resilience Plan (PNRR).
Rome Oncology Conference: Integrating Care and Precision Medicine
A two-day oncology conference in Rome (June 13-14) will focus on integrating hospital and territorial care and precision medicine to improve cancer treatment and patient outcomes in Italy, aligning with the National Recovery and Resilience Plan (PNRR).
Progress
44% Bias Score
Rostov Surgeons Successfully Operate on Advanced Thyroid Cancer
Rostov surgeons successfully removed a large, inoperable thyroid tumor from a 70-year-old woman, highlighting advancements in surgical techniques and the importance of persistent medical care; however, lifelong monitoring is necessary due to the risk of metastasis.
Rostov Surgeons Successfully Operate on Advanced Thyroid Cancer
Rostov surgeons successfully removed a large, inoperable thyroid tumor from a 70-year-old woman, highlighting advancements in surgical techniques and the importance of persistent medical care; however, lifelong monitoring is necessary due to the risk of metastasis.
Progress
44% Bias Score
Online Misinformation Leads Cancer Patients to Reject Proven Treatments
Cancer patients are increasingly rejecting proven treatments for unproven methods like coffee enemas and juice cleanses due to online misinformation, leading to tumor spread and even death, according to oncologists at the ASCO meeting.
Online Misinformation Leads Cancer Patients to Reject Proven Treatments
Cancer patients are increasingly rejecting proven treatments for unproven methods like coffee enemas and juice cleanses due to online misinformation, leading to tumor spread and even death, according to oncologists at the ASCO meeting.
Progress
64% Bias Score
Showing 1 to 12 of 75 results